Developing novel therapies for the prevention and treatment of metastatic cancer
Location: United States, New York
Total raised: $116M
Investors 4
| Date | Name | Website |
| - | Vida Ventu... | vidaventur... |
| - | Droia Onco... | droiaventu... |
| - | Quark Vent... | quarkventu... |
| - | Catalio Ca... | cataliocap... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 07.03.2023 | Series A | $60M | - |
| 06.04.2021 | Seed | $44M | - |
| 11.02.2020 | Seed | $12M | - |
Persons 16
| Date | First Name | Last Name | Title | Location | |||
| - | Rumin | Zhang, PhD | - | linkedin.c... | - | r****g@vol... | - |
| - | Sarah | Bettigole | Vice Presi... | linkedin.c... | - | s********e... | - |
| - | Yazen | Jmeian | Director, ... | linkedin.c... | - | i**o@volas... | - |
| - | Reka | Letso | Laboratory... | linkedin.c... | - | r****o@vol... | - |
| - | Diane | Tager | Chief Oper... | linkedin.c... | - | d****r@vol... | - |
| - | Jonathan | Havel | Senior Sci... | linkedin.c... | - | j****l@vol... | - |
| - | Rachel | Zolot Schw... | - | linkedin.c... | - | r****t@vol... | - |
| - | Albert | Swiston | - | linkedin.c... | - | a******n@v... | - |
| - | Nazario | Bosco | - | linkedin.c... | - | N****O@vol... | - |
| - | Alan | Chiu | Scientist ... | linkedin.c... | - | a***u@vola... | - |
Show more
Mentions in press and media 13
| Date | Title | Description | Source |
| 23.01.2024 | Two more pharmas practice their Accent, invest in $75M serie... | Accent Therapeutics has reeled in investments from two more pharmaceutical companies as part of a $7... | fiercebiot... |
| 07.03.2023 | Volastra Therapeutics Secures $60M in Series A Funding | Volastra Therapeutics, a New York-based clinical stage cancer biotechnology company focused on explo... | finsmes.co... |
| 07.03.2023 | Volastra Therapeutics In-Licenses Clinical Stage KIF18A Inhi... | - | vidaventur... |
| 07.03.2023 | ARCH leads Volastra $60 million financing round | - | archventur... |
| 29.06.2022 | 'Science doesn't care' about markets: Arch raises nearly $3B... | Arch Venture Partners is out to prove there’s still money for the taking for up-and-coming biotechs,... | fiercebiot... |
| 21.03.2022 | Volastra Therapeutics Announces Drug Discovery Collaboration... | Bristol Myers Squibb to leverage Volastra’s proprietary CINtech platform to discover and develop onc... | quarkventu... |
| 06.04.2021 | Volastra Therapeutics Expands Seed Funding to $44M | Volastra Therapeutics, a NYC-based biotechnology company developing novel therapies for the preventi... | finsmes.co... |
| 06.04.2021 | Volastra Therapeutics : Extends Seed Financing to $44 Millio... | Volastra Therapeutics, a biotechnology company developing novel therapies for the prevention and tre... | marketscre... |
| 06.04.2021 | Volastra Therapeutics Scores $12M Seed Round | NEW YORK, NY, Volastra Therapeutics today announced the extension of its original $12 million seed... | vcnewsdail... |
| 11.02.2020 | Volastra Therapeutics Raises $12M in Seed Financing | Volastra Therapeutics, a NYC-based biotechnology company developing novel therapies for the treatmen... | finsmes.co... |
Show more